Harmony Biosciences Holdings, Inc. (HRMY) CEO John Jacobs on Q2 2021 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q2: 2021-08-10 Earnings Summary

EPS of $0.24 beats by $0.07
 | Revenue of $73.82M beats by $4.92M

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2021 Earnings Conference Call August 10, 2021 8:30 AM ET

Company Participants

John Jacobs - President & CEO
Jeff Dierks - Chief Commercial Officer
Jeff Dayno - Chief Medical Officer
Sandip Kapadia - CFO
Lisa Caperelli - IR

Conference Call Participants

Chris Howerton - Jefferies
Graig Suvannavejh - Goldman Sachs
David Amsellem - Piper Sandler

Operator

Good day, and thank you for standing by. Welcome to the Second Quarter 2021 Financial and Business Update Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] Please be advised that today's conference is being recorded. [Operator Instructions].

I would now like to hand the conference over to your speaker, Lisa Caperelli, Head of Investor Relations.

Lisa Caperelli

Thank you, operator. Good morning, everyone, and thank you for joining us today as we review Harmony Biosciences' second quarter 2021 financial performance, and provide business updates.

Before we start, I encourage everyone to go to the Investors section of the Harmony Biosciences website to find the press release and Slides that accompany our discussion today, including a reconciliation of our GAAP to non-GAAP financial measures. At this stage of our life cycle, we believe non-GAAP financial results better represent the underlying economics of our business.

Our presenters on today's call are John Jacobs, President and CEO; Dr. Jeff Dayno, Chief Medical Officer; Jeff Dierks, Chief Commercial Officer; and Sandip Kapadia, CFO.

Moving on to Slide 2, as a reminder, we will be making forward-looking statements today, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult the risk factors referenced in our SEC filings for additional details.

Recommended For You

About HRMY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on HRMY